医药营销
全身性重症肌无力(gMG)新药!优必C5抑制剂zilucoplan和FcRn靶向单克隆抗体Rozanolixizumab期临床成功!
(2022-02-11)- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-10)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-09)
- (2022-02-08)
- (2022-02-08)
- (2022-02-08)
- (2022-02-08)
- (2022-02-08)
- (2022-02-08)
- (2022-02-08)
- (2022-02-07)
- (2022-02-07)
- (2022-02-06)
- (2022-02-06)
- (2022-02-06)
- (2022-02-06)
- (2022-02-05)
- (2022-02-05)
- (2022-02-05)
- (2022-02-05)
- (2022-02-04)
- (2022-02-04)
- (2022-02-03)
- (2022-02-03)
- (2022-02-03)
- (2022-02-03)
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-01)
- (2022-02-01)
- (2022-02-01)
- (2022-02-01)
- (2022-02-01)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-29)